The Korean Journal of Parasitology10.3347/kjp.2017.55.5.4912017555491-503Suppressors for Human Epidermal Growth Factor Receptor 2/4 (HER2/4): A New Family of Anti-Toxoplasmic Agents in ARPE-19 CellsYeong Hoon Kim, Lokraj Bhatt, Hye-Jin Ahn, Zhaoshou Yang, Won-Kyu Lee, Ho-Woo Nam
The Oncologist10.1634/theoncologist.2013-02832014192135-150Human Epidermal Growth Factor Receptor Family-Targeted Therapies in the Treatment of HER2-Overexpressing Breast CancerZeynep Eroglu, Tomoko Tagawa, George Somlo,,,
Breast Care10.1159/0005109982020156579-585Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2Kerstin Riecke, Isabell Witzel,
Cancer Science10.1111/j.1349-7006.2010.01711.x201010211-8Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancerToru Mukohara,
Journal of Bioactive and Compatible Polymers10.1177/0883911517707775201733117-37Specific targeting of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer cells by polyethylene glycol-grafted polyethyleneimine modified with anti-HER2 single-domain antibodyBatoul Saqafi, Fatemeh Rahbarizadeh,,
The Journal of Pathology10.1002/path.498720172434481-495A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasionChristiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, Nicola Herbener, Bianca Riedel, Luisa Schäfer, Hiroshi Nakagawa, Axel Walch, Thomas Reinheckel, Martin Werner, Silke Lassmann,
Human Pathology10.1016/s0046-8177(96)90070-21996273282-289Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometriumH NIIKURA, H SASANO, K KAGA, S SATO, A YAJIMA,
Head & Neck10.1002/hed.234292013363E25-E27Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatmentGerald S. Falchook, Scott M. Lippman, Christel C. Bastida, Razelle Kurzrock,
Cancer Prognosis10.5772/intechopen.782712018The Human Epidermal Growth Factor Receptor 2 (HER2) as a Prognostic and Predictive Biomarker: Molecular Insights into HER2 Activation and Diagnostic ImplicationsDaniela Furrer, Claudie Paquet, Simon Jacob, Caroline Diorio
Journal of Biological Chemistry10.1016/s0021-9258(18)89171-2198526085003-5011Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action.J A Fernandez-Pol,